Literature DB >> 16516963

Human decidual NK cells: unique phenotype and functional properties -- a review.

J Tabiasco1, M Rabot, M Aguerre-Girr, H El Costa, A Berrebi, O Parant, G Laskarin, K Juretic, A Bensussan, D Rukavina, P Le Bouteiller.   

Abstract

Human decidual NK cells are massively recruited at the site of embryonic implantation (decidua basalis). They differ in many ways from their peripheral blood NK cell counterparts in terms of gene expression, phenotype and functionality. The major subpopulation of decidual NK cells is CD56(bright) whereas the minor subset is CD56(dim), contrasting with the peripheral blood NK cells whose major subpopulation is CD56(dim). Decidual NK cell cytolytic function is much reduced despite the presence of several activating receptors and the essential machinery required for lysis. Decidual NK cells produce a number of cytokines that are not normally secreted by peripheral blood NK cells. Human decidual NK cell potential functions at the maternal-fetal interface are not yet clearly established but several hypotheses are being evaluated, including control of extravillous invasion, control of uterine vascular remodeling, and local anti-viral activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516963     DOI: 10.1016/j.placenta.2006.01.009

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  33 in total

1.  Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro.

Authors:  Aleah D Hazan; Samantha D Smith; Rebecca L Jones; Wendy Whittle; Stephen J Lye; Caroline E Dunk
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

2.  Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia.

Authors:  Alison E Wallace; Amanda J Host; Guy S Whitley; Judith E Cartwright
Journal:  Am J Pathol       Date:  2013-10-06       Impact factor: 4.307

Review 3.  Natural killer cells and regulatory T cells in early pregnancy loss.

Authors:  Surendra Sharma
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 4.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 5.  Extravillous trophoblast and decidual natural killer cells: a remodelling partnership.

Authors:  Alison E Wallace; Rupsha Fraser; Judith E Cartwright
Journal:  Hum Reprod Update       Date:  2012-04-20       Impact factor: 15.610

6.  The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.

Authors:  Yan-Hong Li; Wen-Hui Zhou; Yu Tao; Song-Cun Wang; Yun-Lan Jiang; Di Zhang; Hai-Lan Piao; Qiang Fu; Da-Jin Li; Mei-Rong Du
Journal:  Cell Mol Immunol       Date:  2015-01-12       Impact factor: 11.530

7.  Molecular evidence for natural killer-like cells in equine endometrial cups.

Authors:  L E Noronha; K E Huggler; A M de Mestre; D C Miller; D F Antczak
Journal:  Placenta       Date:  2012-02-21       Impact factor: 3.481

Review 8.  Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field.

Authors:  G St J Whitley; J E Cartwright
Journal:  Placenta       Date:  2010-03-31       Impact factor: 3.481

9.  Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.

Authors:  Christine Waasdorp Hurtado; Lucy Golden-Mason; Megan Brocato; Mona Krull; Michael R Narkewicz; Hugo R Rosen
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

10.  Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy.

Authors:  Claudia Carlino; Eleonora Trotta; Helena Stabile; Stefania Morrone; Roberta Bulla; Alessandra Soriani; Maria Luisa Iannitto; Chiara Agostinis; Carlo Mocci; Massimo Minozzi; Cesare Aragona; Giorgia Perniola; Francesco Tedesco; Silvano Sozzani; Angela Santoni; Angela Gismondi
Journal:  J Clin Endocrinol Metab       Date:  2012-07-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.